68Ga-Labeled Benzothiazole Derivatives for Imaging Aβ Plaques in Cerebral Amyloid Angiopathy

Truc T. Huynh, Yujue Wang, Karna Terpstra, Hong Jun Cho, Liviu M. Mirica, Buck E. Rogers

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Timely diagnostic imaging plays a crucial role in managing cerebral amyloid angiopathy (CAA)â" the condition in which amyloid β is deposited on blood vessels. To selectively map these amyloid plaques, we have designed amyloid-Targeting ligands that can effectively complex with 68Ga3+while maintaining good affinity for amyloid β. In this study, we introduced novel 1,4,7-Triazacyclononane-based bifunctional chelators (BFCs) that incorporate a benzothiazole moiety as the Aβ-binding fragment and form charged and neutral species with 68Ga3+. In vitro autoradiography using 5xFAD and WT mouse brain sections (11-month-old) suggested strong and specific binding of the 68Ga complexes to amyloid β. Biodistribution studies in CD-1 mice revealed a low brain uptake of 0.10-0.33% ID/g, thus suggesting 68Ga-labeled novel BFCs as promising candidates for detecting CAA.

Original languageEnglish
Pages (from-to)20339-20346
Number of pages8
JournalACS Omega
Issue number23
StatePublished - Jun 14 2022


Dive into the research topics of '68Ga-Labeled Benzothiazole Derivatives for Imaging Aβ Plaques in Cerebral Amyloid Angiopathy'. Together they form a unique fingerprint.

Cite this